Medication Brand Names Beginning with ‘S’, Page 17

Page 17 of 353 « First Page « … 5 10 … 15 16 17 18 19 … 25 30 35 40 45 … » Last Page »

SAVAYSA (EDOXABAN TOSYLATE)

SAVAYSA is a factor Xa inhibitor indicated: To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF) (1.1) Limitation of Use for…

Daiichi Sankyo Inc.24 April 2020

SAVELLA (MILNACIPRAN HYDROCHLORIDE)

Savella is indicated for the management of fibromyalgia. Savella is not approved for use in pediatric patients [ see Use in Specific Populations (8.4) ]. Savella is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for…

STAT RX USA LLC9 July 2010

Savella (Milnacipran Hydrochloride)

Rebel Distributors Corp1 December 2010

Savella (Milnacipran Hydrochloride)

Savella is indicated for the management of fibromyalgia. Savella is not approved for use in pediatric patients [see Use in Specific Populations (8.4)]. Savella is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the…

Physicians Total Care, Inc.8 November 2011

Savella (Milnacipran Hydrochloride)

Savella is indicated for the management of fibromyalgia. Savella is not approved for use in pediatric patients [see Use in Specific Populations (8.4)]. Savella is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the…

Lake Erie Medical DBA Quality Care Products LLC15 November 2012

Page 17 of 353 « First Page « … 5 10 … 15 16 17 18 19 … 25 30 35 40 45 … » Last Page »

FDA Medwatch

CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets
Tue, 07 Jul 2020. As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing. This testing revealed that some…
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Tue, 07 Jul 2020. Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA,…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.